Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.940
+0.040 (4.43%)
Dec 27, 2024, 4:00 PM EST - Market closed
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $51.39 million as of December 27, 2024. Its market cap has decreased by -33.94% in one year.
Market Cap
51.39M
Enterprise Value
72.51M
1-Year Change
-33.94%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $51.39M, an increase of 834.42%. That is a compound annual growth rate of 14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 51.40M | 4.26% |
| Dec 29, 2023 | 49.30M | -27.07% |
| Dec 30, 2022 | 67.60M | -62.90% |
| Dec 31, 2021 | 182.20M | -47.05% |
| Dec 31, 2020 | 344.10M | 175.72% |
| Dec 31, 2019 | 124.80M | -51.19% |
| Dec 31, 2018 | 255.70M | 37.10% |
| Dec 29, 2017 | 186.50M | 34.37% |
| Dec 30, 2016 | 138.80M | -1.77% |
| Dec 31, 2015 | 141.30M | -38.99% |
| Dec 31, 2014 | 231.60M | 656.86% |
| Dec 31, 2013 | 30.60M | 11.27% |
| Dec 31, 2012 | 27.50M | -3.17% |
| Dec 30, 2011 | 28.40M | 72.12% |
| Dec 31, 2010 | 16.50M | 43.48% |
| Dec 31, 2009 | 11.50M | 475.00% |
| Dec 31, 2008 | 2.00M | -63.64% |
| Dec 31, 2007 | 5.50M | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 52.37M |
| Spero Therapeutics | 51.46M |
| MAIA Biotechnology | 51.42M |
| Kezar Life Sciences | 49.91M |
| Serina Therapeutics | 49.59M |
| iCAD, Inc. | 49.02M |
| Singular Genomics Systems | 48.78M |
| Aileron Therapeutics | 48.75M |